Signing of China Belarus deep cooperation zone and China Belarus international traditional Chinese medicine health industrial park project

发布于: 2021-07-21 00:00

On July 21, with the active promotion of Jintai Academy of culture, the signing ceremony of China Belarus deep cooperation zone and China Belarus international traditional Chinese medicine health industrial park project (hereinafter referred to as traditional Chinese medicine health industrial park project) was held in Qingdao, Beijing and Minsk, Belarus. At the ceremony, Zhongbai Industrial Park Development Co., Ltd., Qingdao Chengyang District People's government, CAMCE International Engineering Co., Ltd. and Zhongheng glory (Beijing) Technology Co., Ltd. signed the cooperation agreement on interactive strategic cooperation between Zhongbai Industrial Park and the proposed Qingdao Zhongbai international traditional Chinese medicine health industrial park and China Belarus deep cooperation zone.

 

 

Yaroshenko, director of the China Belarus Industrial Park Management Committee, thanked all parties for their support in promoting the high-quality development and construction of China Belarus Industrial Park. He said that the Belarusian government will actively support the development of traditional Chinese medicine industry in China Belarus Industrial Park. He mentioned that on June 11 this year, Decree No. 215 signed by President Lukashenko "on the amendment to the presidential decree of the Republic of Belarus" expanded the priority development areas of the park, including biopharmaceuticals, medical products, medical services, laboratory diagnosis and so on. He firmly believes that the establishment of a traditional Chinese medicine health industrial park in Qingdao will achieve coordinated development with the Sino Belarus Industrial Park, and the project will inject new impetus into the development of the park and even the whole traditional Chinese medicine industry in Belarus; The park management committee will cooperate with relevant departments and units in Belarus to provide all-round support for the project.

 

Wang Kaixuan, director of the Eurasian Department of the Ministry of Commerce of China, said that the China Belarus Industrial Park is an important economic and trade cooperation zone between China and Belarus. This year, the park welcomed the entry of the first traditional Chinese medicine enterprise, and the newly issued presidential decree also included the traditional Chinese medicine industry and other medical industries into the priority development areas of the park. The agreement signed today will further promote the cooperation and development between China Belarus Industrial Park and Qingdao in the medical and pharmaceutical industries, make new contributions to the construction of a human health community between China and Belarus, and constantly promote the high-quality development of China Belarus Industrial Park.

 

Yan Gang, general manager of Zhongbai Industrial Park Development Co., Ltd., thanked all participants for their attention and support to the Zhongbai Industrial Park project. He said that the human health community is an important part of the community with a shared future for mankind. The park actively attracts international cooperation projects in the traditional Chinese medicine industry to settle in the park, and is committed to promoting Biopharmaceutical Enterprises from Eurasian Union countries to invest and cooperate in Qingdao, China. The development company will take this signing cooperation as an opportunity to promote more exchanges and cooperation in the field of life and health between the two countries.

 

At this event, the Hetao sub district office of Chengyang District, Qingdao signed the investment agreement of Zhongbai international traditional Chinese medicine health industrial park with Zhongheng glory (Beijing) Technology Co., Ltd.

 

Source: Xinhuanet, reference news, overseas network, Sina, etc

Share

Recommended articles

  • 2021-11-11
      The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released   Zhou Xingting   Yao jian   "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.     The world's first effective Chinese patent medicine for COVID-19 treatment   Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia    On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
  • 2021-11-10
      On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.   China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony     Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...
  • 2021-11-10
      On November 5, when the China International Import Expo opened, the China-Belarus Industrial Park held a press conference on Traditional Chinese medicine products of the Industrial Park and the signing ceremony of the cooperation agreement between the industrial park, demonstrating the major achievements of china-Belarus anti-epidemic cooperation.     According to reports, qingfu capsule series, originated from the classic formula in Treatises on Typhoid fever 1800 years ago, combined with the successful experience of Traditional Chinese medicine in fighting malignant infectious diseases such as The Outbreak of Blast, combined with modern medicine, in view of novel coronavirus characteristics of rapid transmission, rapid disease progression, high mortality and many sequelae, is a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, redu...